Stock listing
Reviva Pharmaceuticals Holdings, Inc.
Selected listing: RVPH · NASDAQ · USD · US
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH), Health Technology. Latest release Jun 23, 2026: Reviva Pharmaceuticals to Present at the Life Sciences…
- Ticker
- NASDAQ:RVPH
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Reviva Pharmaceuticals Holdings, Inc.
The company focuses on developing innovative therapies for central nervous system disorders and other serious conditions. Reviva is committed to advancing its pipeline of drug candidates to address unmet medical needs in the pharmaceutical market.
Latest news from Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals to Present at the Life Sciences Investor Forum on June 24th
June 23, 2026
Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 12, 2026
Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications
April 23, 2026
Reviva Announces Letter to Shareholders
April 15, 2026
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights
March 29, 2026
Research Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals Holdings, Inc. company profile
View the public company page for Reviva Pharmaceuticals Holdings, Inc. on 6ix.
Reviva Pharmaceuticals Holdings, Inc. news
Read company news and market updates connected to Reviva Pharmaceuticals Holdings, Inc..
Reviva Pharmaceuticals Holdings, Inc. investor events
Find investor webinars, events, and replay context for Reviva Pharmaceuticals Holdings, Inc..